Total item
Cart Subtotal
$0.00 Biological Activity
Lapatinib is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway.
Targets
| Target | Value |
|---|---|
| ErbB2 | IC50: 9.2nM |
| EGFR | IC50: 10.8nM |
| ErbB4 | IC50: 367nM |
| c-Src | IC50: 3.5μM |
| C-Raf-1 | IC50: >10μM |
| MEK | IC50: >10μM |
| ERK | IC50: >10μM |
| c-Fms | IC50: >10μM |
| CDK1 | IC50: >10μM |
| CDK2 | IC50: >10μM |
| p38 | IC50: >10μM |
| Tie-2 | IC50: >10μM |
| VEGFR2 | IC50: >10μM |
| In vitro (25°C) | DMSO | 100 mg/mL (172.09 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 15% Captisol | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 17.21 mL | 86.04 mL | 172.09 mL |
| 0.5 mM | 3.44 mL | 17.21 mL | 34.42 mL |
| 1 mM | 1.72 mL | 8.6 mL | 17.21 mL |
| 5 mM | 0.34 mL | 1.72 mL | 3.44 mL |
*The above data is based on the productmolecular weight 581.1 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11752 |
|---|---|
| Actions | N/A |
| M. Wt | 581.1 |
| Formula | C29H26ClFN4O4S |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 231277-92-2 |
| Synonyms | N/A |
| SMILES | CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Pelitinib (EKB-569)
Pelitinib (EKB-569) is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity.
PF299804 (Dacomitinib, PF299)
PF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HE…
ASP8273 (Naquotinib)
ASP8273 is an orally available, irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with po…
AG-1478 (Tyrphostin AG-1478)
AG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
SU-5402
SU-5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor…
AV-412
AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth factor receptor (EGFR) and the human epidermal growth facto…
WHI-P180
WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
Gefitinib (Iressa)
Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
Keywords:buy Lapatinib (free base) | Lapatinib (free base) Supplier | purchase Lapatinib (free base) | Lapatinib (free base) cost | Lapatinib (free base) manufacturer | order Lapatinib (free base) | Lapatinib (free base) distributor | buy 231277-92-2| 231277-92-2 Supplier | purchase 231277-92-2 | 231277-92-2 cost | 231277-92-2 manufacturer | order 231277-92-2 | 231277-92-2 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.